{"chunk_id": "medquad__chunk_3407", "source": "medquad", "text": "d to grow and divide. LOXO-101 and entrectinib are kinase inhibitors being studied to treat congenital mesoblastic nephroma.     -  Histone methyltransferase inhibitors: This targeted therapy slows down the cancer cell's ability to grow and divide. Tazemetostat is being studied in the treatment of rhabdoid tumor of the kidney.\n                \n                \n                    Patients may want to think about taking part in a clinical trial.\n                    For some patients, taking part"}